Bind Biosciences Inc.

Bind Biosciences Inc. of Cambridge, Mass., has received a three-year, $2 million award from the National Institute of Standards and Technology of Gaithersburg, Md. The grant will fund the continuing development of a platform for the high-throughput formulation and selection of targeted nanoparticles. The company hopes to use the device to create a class of therapeutics based on optimally engineered particles.





LATEST NEWS

• Cognex Names Former Siemens VP Dennis Fehr CFO
  May 2, 2024
• 3D Holography Integrated Glasses Could Unlock Mixed Reality
  May 2, 2024
• Generative AI Achieves Superresolution with Minimal Tuning
  May 2, 2024
• AmeriCOM Adds President and CEO: People in the News: 5/1/24
  May 1, 2024
• Machine Learning Pushes High-Power Lasing Limits
  May 1, 2024
• IPG Names Industry Veteran Mark Gitin CEO
  Apr 30, 2024
• 16th Biannual Optatec Conference Continues in Frankfurt
  Apr 30, 2024
• Celestial Surface Mapping Tech Combines Established Techniques
  Apr 30, 2024